Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis

Table 2

Drug concentrations tested in MGIT 960 and L-J proportion method.

Drug	Concentration evaluated (μg/mL)
	MGIT960	L-J
Moxifloxacin	0.25, 0.5, 1.0, 2.0, 4.0	2.0
Levofloxacin	0.25, 0.5, 1.0, 2.0, 4.0, 8.0	2.0
Kanamycin	0.625, 1.25, 2.5, 5.0, 6.0, 10.0	40.0
Capreomycin	0.625, 1.25, 2.5, 5.0	40.0
Ethionamide	0.625, 1.25, 2.5, 5.0	40.0
ρ-aminosalicylic acid	0.5, 1.0, 2.0, 4.0, 8.0, 16.0	1.0